HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Beauty Health Cosmetic Ingredients

Over The Counter 1 March 2024: The Emerging Benefits Of ‘Beauty-From-Within,’ Featuring Kenvue’s Paul LaTerra

  • Interviews

Executive Summary

In this episode of Over the Counter, HBW Insight speaks to Paul LaTerra, Director, R&D, Global Hair and Scalp for Kenvue, a New Jersey-based consumer health company that markets skin care brands Neutrogena, Aveeno and Lubriderm. We discuss growth of the beauty-from-within supplements market, how the products complement topical skin care and hair formulas and the growing body of research demonstrating significant skin and hair health benefits. 

 

 

 

Open Media

 

Further Reading:

'The Problem Is In-Store': Kenvue CEO Mongon Lays Out Plan To Kickstart Skin Health & Beauty

Kenvue Prioritizes Growing 15 Brands In Pivot To Recovering Marketplace Prominence 

Holland & Barrett's Trends for 2024: Nootropics, Menstrual Health, 'New Wave Aging'

Holland & Barrett's Trends for 2023: Women's Health, Health Tech, Ayurveda And Cosmeceuticals

 

Table

View full table

Topics

Tags:
Beauty Health Cosmetic Ingredients
Latest Headlines

DSM-Firmenich Flags Fish Oil Supplement Shortage

Over The Counter: Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta

Coty’s Social Media Investments Have CoverGirl, Rimmel On More Lips, Minds And Receipts

Opill Launch Delivers For Perrigo While Growing Pains Slow Overall First-Quarter Results

See All
UsernamePublicRestriction

Register

RS154464

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By